Sweetgreen is trading at $5.34 (-9.54%) after its August 6 earnings report missed expectations and management sharply reduced 2026 guidance.

  • Q2 same-store sales fell 6.2%, reflecting weaker traffic and product mix
  • Full-year same-store sales guidance worsened to -7% to -8%, from -2% to -4%; adjusted EBITDA guidance now implies a $23 million-$27 million loss
  • Management cited reduced demand following mid-July cyclosporiasis concerns, despite no indication Sweetgreen caused the outbreak